Literature DB >> 30365995

Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis.

Kevin R Patel1, Supriya Immaneni1, Vivek Singam1, Supriya Rastogi1, Jonathan I Silverberg2.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is associated with psychologic distress. However, previous studies found conflicting results about whether AD is associated with increased depression or suicidality.
OBJECTIVES: To determine the complex relationship between AD and depression.
METHODS: A systematic review of all published observational studies in the MEDLINE, PubMed, Embase, Global Resource for Eczema Trials (GREAT), Latin American and Caribbean Health Sciences (LILACS), the Cochrane Library, Scopus, and PsychInfo databases that analyzed depression in AD was performed. Two reviewers performed study title and/or abstract review and data abstraction. Pooled meta-analysis was performed by using random-effects weighting.
RESULTS: Overall, 106 studies met the inclusion criteria; 36 had sufficient data for meta-analysis. The prevalence of any depression was higher in persons with versus without AD (20.1% vs 14.8%). Similar results were found in sensitivity analyses of studies assessing clinical depression, depressive symptoms, and adults; studies with healthy controls; and studies of low and high study quality. AD was associated with significantly higher depression scale scores, parental depression, antidepressant use, and suicidality. No publication bias was detected. LIMITATIONS: Individual-level data were not available.
CONCLUSIONS: Patients with AD have higher odds of depression and suicidality.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antidepressant; atopic dermatitis; comorbidity; depression; eczema; evidence; mood; suicidal ideation; suicide

Mesh:

Year:  2018        PMID: 30365995     DOI: 10.1016/j.jaad.2018.08.063

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  35 in total

1.  General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France.

Authors:  Angèle Soria; Claire Thénié; Christina Bienenfeld; Delphine Staumont-Sallé
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

2.  Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis.

Authors:  Silvia Mariel Ferrucci; Simona Tavecchio; Luisa Angileri; Teresa Surace; Emilio Berti; Massimiliano Buoli
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

Review 3.  National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021).

Authors:  Mohammad I Fatani; Afaf A Al Sheikh; Mohammed A Alajlan; Ruaa S Alharithy; Yousef Binamer; Rayan G Albarakati; Khalidah A Alenzi; Amr M Khardaly; Bedor A Alomari; Hajer Y Almudaiheem; Ahmed Al-Jedai; Maysa T Eshmawi
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-04

4.  What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review.

Authors:  Marissa T Ayasse; Adnan Ahmed; Maria L Espinosa; Christina J Walker; Muhammad Yousaf; Jacob P Thyssen; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2020-11-22       Impact factor: 3.017

5.  Mental Health Symptoms and Functional Impairment in Children With Atopic Dermatitis.

Authors:  Brian T Cheng; Anna B Fishbein; Jonathan Ian Silverberg
Journal:  Dermatitis       Date:  2021 Sep-Oct 01       Impact factor: 4.845

Review 6.  Review of the holistic management of pediatric atopic dermatitis.

Authors:  Armaan Guraya; Karan Pandher; Caroline L Porter; Sarah Taylor; Joseph Jorizzo; Lindsay Strowd; Rajesh Balkrishnan; Steven Feldman
Journal:  Eur J Pediatr       Date:  2022-01-22       Impact factor: 3.183

7.  Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.

Authors:  Jonathan I Silverberg; Jacob P Thyssen; Eric L Simpson; Gil Yosipovitch; Sonja Ständer; Hernan Valdez; Ricardo Rojo; Pinaki Biswas; Daniela E Myers; Claire Feeney; Marco DiBonaventura
Journal:  Am J Clin Dermatol       Date:  2021-05-05       Impact factor: 7.403

8.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

Review 9.  Recent advances in atopic dermatitis.

Authors:  Kangmo Ahn; Byung Eui Kim; Jihyun Kim; Donald Ym Leung
Journal:  Curr Opin Immunol       Date:  2020-04-13       Impact factor: 7.486

10.  Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities.

Authors:  Giuseppe Lanza; Filomena Irene Ilaria Cosentino; Raffaele Ferri; Bartolo Lanuzza; Maddalena Siragusa; Mariangela Tripodi; Carmelo Schepis
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.